TABLE 1.
Human MSC | Mouse MSC | ||||
---|---|---|---|---|---|
Namea | Other name(s)a | restingb | +hPBMCc | restingb | +mPBMCd |
CC chemokines | |||||
CCL1 | I‐309, TCA‐3 | + | |||
CCL2 | MCP‐1 | ++ | ++ | +++ | ++++ |
CCL3 | MIP‐1α | + | |||
CCL4 | MIP‐1β | ++ | |||
CCL5 | RANTES | + | ++ | + | ++++ |
CCL6 | C10, MRP‐2 | ||||
CCL7 | MARC, MCP‐3 | − | ++ | ++ | |
CCL8 | MCP‐2 | − | ++ | ||
CCL9/CCL10 | MIP‐1δ, CCF18 | + | + | ||
CCL11 | Eotaxin | − | − | ||
CCL12 | MCP‐5 | ++ | |||
CCL13 | MCP‐4, NCC‐1 | − | |||
CCL14 | HCC‐1, NCC‐2 | ||||
CCL15 | MIP‐1δ, HCC‐2 | ||||
CCL16 | NCC‐4 | ||||
CCL17 | TARC, ABCD‐2 | − | + | ++ | |
CCL18 | MIP‐4, PARC | + | |||
CCL19 | MIP‐3β, Exodus‐3 | + | |||
CCL20 | LARC, Exodus‐1 | ||||
CCL21 | SLC, Exodus‐2 | − | |||
CCL22 | MDC | + | |||
CCL23 | MIP‐3 | − | |||
CCL24 | Eotaxin‐2 | − | |||
CCL25 | TECK | ||||
CCL26 | Eotaxin‐3 | + | |||
CCL27 | CTACK, Eskine | + | |||
CCL28 | MEC | ||||
CXC chemokines | |||||
CXCL1 | GRO1 | − | +++ | +++++ | |
CXCL2 | MIP‐2α/GRO2 | +++ | +++++ | ||
CXCL3 | MIP‐2β/GRO3 | ||||
CXCL4 | PF‐4 | ||||
CXCL5 | ENA78 | ++++ | |||
CXCL6 | GCP‐2 | ||||
CXCL7 | NAP‐2 | ++ | |||
CXCL8 | IL‐8/NAP‐1 | ++ | ++ | ||
CXCL9 | MIG | − | ++ | +++++ | |
CXCL10 | IP‐10 | + | ++ | +++++ | |
CXCL11 | I‐TAC/IP‐9 | ++ | ++ | ||
CXCL12 | SDF‐1 | + | + | + | |
CXCL13 | BCA‐1 | − | ++ | ||
CXCL14 | BRAK/bolekine | ||||
CXCL15 | Lungkine, WECHE | ||||
CXCL16 | SRPSOX | ||||
CXCL17 | DMC, VCC‐1 | ||||
C chemokines | |||||
XCL1 | Lymphotactine α | ||||
XCL2 | Lymphotactine β | ||||
CX3C chemokines | |||||
CX3CL1 | Fractalkine | ++ | ++++ |
Note: Qualitative units of expression: (−) absent, (+) to (++++), present with increasing levels. Boxes left blank were not evaluated.
Chemokine nomenclature informed by Laing and Secombes.75
Expression by MSCs in culture, informed by Chen et al.55
Expression human MSC co‐cultured with activated human PBMCs, informed by Chinnadurai et al.74
Expression mouse MSC co‐cultured with activated mouse PBMCs, informed by Ren et al.56